Division of Urology, Department of Surgery, University of Alabama, Birmingham, Alabama, USA.
J Endourol. 2009 Nov;23(11):1821-4. doi: 10.1089/end.2008.0115.
We reviewed our experience with percutaneous nephrolithotomy (PCNL) in patients with renal allografts over 19 years.
We cross-referenced all renal allograft recipients at our institution with all PCNLs performed. We identified 16 renal allograft recipients who underwent a total of 21 PCNL procedures between 1986 and 2005. These charts were abstracted and the outcomes reviewed.
The mean follow-up was 7.2 years. No loss of renal function occurred in the perioperative period. Five patients lost graft function during the follow-up period; however, none of these patients' loss of function was related to the PCNL. No patient had sepsis. Thirteen of the 16 patients were rendered stone free during long-term follow-up.
PCNL is a safe and effective method of treating nephrolithiasis in a transplanted kidney.
我们回顾了 19 年来我们在移植肾患者中行经皮肾镜取石术（PCNL）的经验。
我们在本院接受移植肾治疗的所有患者中进行了 PCNL 手术的交叉参考。我们共确定了 16 名移植肾受者，他们在 1986 年至 2005 年间共接受了 21 次 PCNL 手术。我们对这些病历进行了摘录，并对结果进行了回顾。
平均随访时间为 7.2 年。围手术期无肾功能丧失。5 名患者在随访期间丧失了移植肾功能；然而，这些患者的功能丧失都与 PCNL 无关。无患者发生脓毒症。16 名患者中的 13 名在长期随访中结石清除。
PCNL 是治疗移植肾肾结石的一种安全有效的方法。
